97.jpeg)
The UK government on Wednesday said that Serum Institute of India's Covishield qualified as an approved vaccine against COVID-19. The approval was part of the revised travel advisory issued by the UK.
However, Indians who have taken the Covishield vaccine will still have to remain in quarantine due to a 'certification' issue according to the UK government.
In its latest travel update, the UK has said that from October 4, one will qualify as fully vaccinated if they are “vaccinated under an approved vaccination programme in the UK, Europe, USA or UK vaccine programme overseas with a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea or Taiwan”. It further mentions, “Formulations of the 4 listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, qualify as approved vaccines.”
The UK government on Wednesday said that Serum Institute of India's Covishield qualified as an approved vaccine against COVID-19. The approval was part of the revised travel advisory issued by the UK.
However, Indians who have taken the Covishield vaccine will still have to remain in quarantine due to a 'certification' issue according to the UK government.
In its latest travel update, the UK has said that from October 4, one will qualify as fully vaccinated if they are “vaccinated under an approved vaccination programme in the UK, Europe, USA or UK vaccine programme overseas with a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea or Taiwan”. It further mentions, “Formulations of the 4 listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, qualify as approved vaccines.”
